In the interview, Pulnovo Medical emphasized its mission to create cutting-edge medical devices that address the evolving needs of healthcare providers and patients. “Innovation is at the core of our strategy,” Cynthia stated. “We strive to develop solutions that not only meet current healthcare challenges but also anticipate future needs.”

Advancements in Medical Technology

Pulnovo Medical continues to push the boundaries of medical technology, with a strong focus on research and development. “Our dedicated team invests significantly in R&D to ensure our products are effective and reliable,” Cynthia explained. “By harnessing the latest scientific advancements, we aim to improve patient outcomes and streamline healthcare processes.”

Accessibility of Healthcare Solutions

The company recognizes the importance of making healthcare innovations widely accessible. “We are committed to developing solutions that can be implemented in diverse healthcare settings,” Cynthia noted. “Our goal is to ensure that every patient, regardless of their circumstances, can benefit from the advancements we bring to the market.”

Collaborative Efforts for Better Healthcare

Cynthia highlighted the necessity of collaboration within the healthcare sector. “Partnerships with healthcare providers, academic institutions, and policymakers are vital for driving innovation. Together, we can create an ecosystem that fosters growth and addresses the complex challenges in healthcare today,” she stated.

As Pulnovo Medical forges ahead, the company remains dedicated to its mission of transforming healthcare through technology. “We believe in the potential of medical innovation to change lives for the better. Our commitment to quality and accessibility will guide our efforts as we continue to expand our impact in the global healthcare landscape,” Cynthia concluded.

About PADN

Pulmonary Artery Denervation (PADN) is a percutaneous pulmonary artery intervention procedure that uses a PADN catheter to deliver radiofrequency energy to the sympathetic nerves in the outer membrane of the pulmonary artery, resulting in the disappearance of the myelin sheath of the nerves and the fusion of the axons, which inhibits sympathetic activity, increases cardiac output, reduces pulmonary artery pressure , inhibits the pathologic remodeling of the pulmonary arteries, improves the patient's exercise endurance and cardiac function, and achieves long-term benefits from a single minimally invasive procedure.

About Pulnovo Medical

Pulnovo Medical Limited, is a globally recognized device pioneer in the treatment for pulmonary hypertension and heart failure. Established in 2013 and rooted in innovation, Pulnovo Medical is committed to leveraging our deep expertise in the science of breakthrough technologie with the goal to market our innovative therapeutic solutions and benefit patients around the world.